Sentinel node imaging via a nonparticulate receptor-binding radiotracer

Journal of Nuclear Medicine

Volumn 38, Issue 4, 1997, Pages 530-535

  Vera, David R ^a,b   Wisner, Erik R ^a   Stadalnik, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

lymphoscintigraphy; receptor binding radiopharmaceutical; sentinel node imaging

Indexed keywords

MANNOSE BINDING PROTEIN; PENTETATE TECHNETIUM TC 99M; POLYLYSINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG ACCUMULATION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; RETICULOENDOTHELIAL NEOPLASM;

ANIMALS; CARRIER PROTEINS; LECTINS, C-TYPE; LYMPH NODES; MANNOSE; MANNOSE-BINDING LECTINS; POLYLYSINE; RABBITS; RECEPTORS, CELL SURFACE; TECHNETIUM TC 99M PENTETATE;

EID: 0030899565     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Morton DL. Wen D-R, Wong JH. et ni. Technical details of intraoperative lymphatic mapping tor early stage melanoma. Arch Sttrg 1992:127:392-399.
2. Alex JC, K mg DN. Gamma-probe guided localization of lymph nodes. Surg OHO 1993:2:137 143.
3. Krag ON. Weaver JC. Alex JC, Fairbank JT. Surgical resection and radiolocalizatkn of the sentinel lymph node in breast cancer using a gamma probe.J Surg Oncol 1993:2:335-340.
4. Uren RF. Howman-Giles RB, Thompson JF. et al. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res 1994:4:395-399.
5. van der Veen H, Hoekstra OS, Paul MA, Cuesta MA. Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadeneetomy. Br J Surg 1994:81:1769-1970.
6. Krag DN. Meijer SJ. Weaver DL. et al. Minimal-access surgery for staging t f malignant melanoma. Arch Surg 1995:130:654-658.
7. Sacks G A. Sandier MP, Bom M.. Lymphoscintigraphy as an adjunct ive procedure in the perioperative assessment of patients undergoing microlymphalicovenous anastomoses. Clin Nucl Med 1983:8:309-311.
8. X. Hung JC, Wiscman GA, Wahner HW. Mullan BP. Taggart TR. Dünn WL. Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy. J Sucl Mud 1995; 36:1895-1901.
9. Pijpers R. Collet GJ, Meijer S. Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Clin Med 1995:22:1238-1241.
10. Uren RF, Howman-Giles RB, Thompson JF. et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995:36:1775-1780.
11. Albertini JJ, Cruse CW, Rapaport D. et al. Intraoperativc radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996:223:217-224.
12. Vera DR, Krohn K.A, Stadalnik RC, Scheibe PO. Technetium-99m galactosylneoglycoalbumin: in vivo characterization of receptor-mediated binding. J. Nucl Med 1984:25:779-787.
13. Stadalnik RC, Vera DR, Woodle ES, et al. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J Nucl Mal 1985:26:1233-1242.
14. Vera DR, Stadalnik RC, Kudo M. Krohn KA. Radiopharmaceutical preparation of technetium-99m-galactosyl-neoglycoalbumin. Methods Eniymol 1994:247:402-408.
15. Steer CJ. Ashwell G. Receptor-mediated endoeytosis: mechanisms, biologic function, and molecular properties. In: Zakim D, Boyer TD. eds. Hepatologv: a textbook a liver disease, 2nd ed. Philadelphia: W.B. Saundcrs; 1990:137-182.
16. Achord DT. Brot FE. Sly WS. Inhibition of the rat clearance system for agalactoorosomucoid by yeast mannans and by mannose. Biochem Biophvs Ras Commun 1977:77:409-4'l 5.
17. Stahl PD. Rodman JS, Miller MJ, Schlcsinger PH. Evidence for receptor-mediated binding of glycoproieins, glycoconjugates and lysosomal glycosidases by alveolar macrophages. Proc Nail Acad Sei USA 1978:75:1399-1403r
18. Praaning-Van Dalcn DP, DeEeeuw AM, Brouwer A. Knook DL. Rat liver endothelial cells have a greater capacity than Kupffer cells to endocytose.V-acetylglucosamineand mannose-terminated glycoproteins. Hepatology 1987:7:672-679.
19. Kozutsumi Y. Kawasaki T, Yamashina I. Isolation and characterization of a mannanbinding protein from rabbit serum. Biochem Biophys Res Commun 1980:95:658-665.
20. Kawasaki T. Mizuno Y. Masuda T, Yamashina I. Mannan-binding protein in lymphoid tissues of rats. J Biochem (Tokyo) 1980:88:1891-1894.
21. Krejcarek GF. Tucker KL. Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Commun 1977:77:581-583.
22. Vera DR, Buonocore Mil. Wisner ER. Katzberg R W. Stadalnik RC. A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver. At-ad Radial 1995:2:497 507.
23. Körösy F, Bârczai-Martos M. Preparation of acetobrome-sugars. Nature 1950:165: 369.
24. Chipowsky S, Lee YC. Synthesis of l-thioaldosides having an amino group at the aglycon terminal. Carbohydr Res 1973:31:339 346.
25. Lee RT, Lee YC. Preparation of new co-aldehydroalkyl 1-thio-D-glycopyranosides and their coupling to bovine serum albumin by reductive alkylation. C'arbohydr Res 1982:101:49-55.
26. Vera DR. Topcu S. Stadalnik RC. In vitro quantification of asialoglycoprotein receptor density from human hepatic microsamples. Methods Knzymol 1995:247:394-402.
27. Barone R. Pavaux C. Blin PC. Cuq P. Atlas d'anatomie du lapin. Paris: Masson; 1973:129-143.
28. Robinson DS, Sample WF, Fee HJ, Holmes FC, Morton DL. Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning. Sui-g Forum 1977;28:147-148.
29. Alavi A. Staum MM, Sheosl FB. Bloch PH. Tecrmetium-99m-stannous phytate as an imaging agent lor lymph nodes. J Nucl Med 1978;19:422-426.
30. Bennett LR. Lago Ci. Cutaneous lymphoscintigraphy in malignant melanoma. Semin Mud Med 1983:13:61-69.
31. Glass EC, Essner R, Giuliano A, Morton DL. Comparative efficacy of three lymphoscintigraphic agents. J Nucl Med 1995;36:f99P.
32. Egc NG. Internal mammary lymphoscintigraphy. Radiology1 1976;! 18:101-107.
33. Henze E, Scheiben HR, Collins JD, Najafi A, Barrio JR. Bennett LR. Lymphoscintigraphy with """'Tc-labeled dextran. J NucI Med 1982;23:923-929.
34. Doty P. Imahori K, Klemperer E. The solution properties and configurations of a polyampholytic polypeptide: copoly-L-lysine-L-glutamic acid. Prnc Nail Acad Sei USA 1958:44:424-431.
35. Tanford C. Physical chemistry of macromolecules. New York: John Wiley & Sons Inc.; 1961.
36. Ege E. Warbick-Cerone A, Bronskill MJ. Radionuclide lymphoscintigraphy-an update. In: Sodd VJ, Hoogland DR, Allen DR. Ice RD, Sorenson JA, eds. Radiophat'maeeutieals II. Proceedings of the 2nd International Symposium on Radiopharmaceuficah. New York: Society of Nuclear Medicine; 1979:241-258.
37. Kapteijn BAE, Panday RKJB, Liem 1H. et al. Lymphoscintigraphy and intraoperative gamma probe detection of the first draining lymph node in clinically localized melanoma. J Nucl Med 1995;36:222P.
38. Taylor S, Murray D, Herd S, Vansant J. Alazraki N. The importance of dynamic lymphoscintigraphy in detecting the sentinel node. J Nucl Med 1995;36:223P.
39. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
40. Seymour LW. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst 1992:9:135-187.
41. Krimck NL, Rihovâ B. Ulbrich K. Strohalm J. Kopecek J. Synthesis of AM2hydroxypropyl)methacrylamide copolymer-anti-Thy 1.2 antibody-chlorin e(, conjugates and a preliminary study of their photodynamic effect on mouse splenocytes in vitro. Makromol Chem 1990;191:839-856.
42. Tomalia DA, Baker H. Deward J, et al. A new class of polymers: starburst-dendritic macromolecules. Polymer J 1985; 17:117 -132.
43. Molteni L. Dextrans as drug carriers, lu: Gregoriadis G, éd. Drug carriers in biology and medicine. San Diego: Academic Press: 1979:107-125.
44. Lee YC. Neoglycoconjugates: genera] considerations. In: Lee YC. Lee RT, eds. Neoglvcoconjugatcs: preparation and applications. San Diego: Academic Press: 1994:3 21.
45. Vera DR. Krohn KA. Scheibe PO, Stadalnik RC. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Engr 1985: 32:312-322.